NASDAQ: IZTC
Invizyne Technologies Inc Stock

$15.50-0.57 (-3.55%)
Updated Feb 10, 2025
IZTC Price
$15.50
Fair Value Price
N/A
Market Cap
N/A
52 Week Low
$8.50
52 Week High
$23.00
P/E
-19.14x
P/B
N/A
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$70.07k
Earnings
-$5.12M
Gross Margin
100%
Operating Margin
-7,143.08%
Profit Margin
-7,312.7%
Debt to Equity
-1.99
Operating Cash Flow
-$4M
Beta
-0.32
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine IZTC's potential to beat the market

Zen Rating Component Grades

N/A
Value
N/A
Growth
N/A
Momentum
N/A
Sentiment
N/A
Safety
N/A
Financials
N/A
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Biotech

Industry Rating
F
IZTC
Ranked
Unranked of 557

Top Ranked Stocks in Industry

View Top Biotech Stocks

Be the first to know about important IZTC news, forecast changes, insider trades & much more!

IZTC News

Overview

Due Diligence Score

Industry Average (23)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how IZTC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

IZTC is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
IZTC is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
IZTC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more IZTC due diligence checks available for Premium users.

Valuation

IZTC price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-19.14x
Industry
-154.48x
Market
31x

IZTC's financial health

Profit margin

Revenue
$0.0
Net Income
-$1.7M
Profit Margin
0%
IZTC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
IZTC's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$3.6M
Liabilities
$7.2M
Debt to equity
-1.99
IZTC's short-term liabilities ($5.80M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
IZTC's short-term assets ($1.42M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
IZTC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
IZTC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$541.5k
Investing
$30.9k
Financing
$586.4k
IZTC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

IZTC vs Biotech Stocks

TickerZen RatingMarket Cap1d %P/EP/B
ACETD$74.16M-6.74%-0.53x0.35x
ABCLD$892.01M-2.58%-4.95x0.83x
AAPGN/A+1.23%N/AN/A
ABUSC$631.01M-2.92%-7.74x5.90x
ABSID$497.33M-7.28%-4.66x2.47x

Invizyne Technologies Stock FAQ

What is Invizyne Technologies's quote symbol?

(NASDAQ: IZTC) Invizyne Technologies trades on the NASDAQ under the ticker symbol IZTC. Invizyne Technologies stock quotes can also be displayed as NASDAQ: IZTC.

If you're new to stock investing, here's how to buy Invizyne Technologies stock.

What is the 52 week high and low for Invizyne Technologies (NASDAQ: IZTC)?

(NASDAQ: IZTC) Invizyne Technologies's 52-week high was $23.00, and its 52-week low was $8.50. It is currently -32.61% from its 52-week high and 82.35% from its 52-week low.

How much is Invizyne Technologies's stock price per share?

(NASDAQ: IZTC) Invizyne Technologies stock price per share is $15.50 today (as of Feb 10, 2025).
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.